Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Head and Neck Pathology
Published in: Head and Neck Pathology 3/2019

01-09-2019 | Invited Review

Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms

Authors: Peter P. Luk, Christina I. Selinger, Wendy A. Cooper, Annabelle Mahar, Carsten E. Palme, Sandra A. O’Toole, Jonathan R. Clark, Ruta Gupta

Published in: Head and Neck Pathology | Issue 3/2019

Login to get access

Abstract

Head and neck pathology present a unique set of challenges including the morphological diversity of the neoplasms and presentation of metastases of unknown primary origin. The detection of human papillomavirus and Epstein–Barr virus associated with squamous cell carcinoma and newer entities like HPV-related carcinoma with adenoid cystic like features have critical prognostic and management implications. In salivary gland neoplasms, differential diagnoses can be broad and include non-neoplastic conditions as well as benign and malignant neoplasms. The detection of specific gene rearrangements can be immensely helpful in reaching the diagnosis in pleomorphic adenoma, mucoepidermoid carcinoma, secretory carcinoma, hyalinizing clear cell carcinoma and adenoid cystic carcinoma. Furthermore, molecular techniques are essential in diagnosis of small round blue cell neoplasms and spindle cell neoplasms including Ewing sarcoma, rhabdomyosarcoma, synovial sarcoma, biphenotypic sinonasal sarcoma, dermatofibrosarcoma protuberans, nodular fasciitis and inflammatory myofibroblastic tumor. The detection of genetic rearrangements is also important in lymphomas particularly in identifying ‘double-hit’ and ‘triple-hit’ lymphomas in diffuse large B cell lymphoma. This article reviews the use of in situ hybridization in the diagnosis of these neoplasms.
Literature
1.
Brunner M, Gore SM, Read RL, Alexander A, Mehta A, Elliot M, et al. Head and neck multidisciplinary team meetings: effect on patient management. Head Neck. 2015;37:1046–50.CrossRefPubMed
2.
3.
Schildhaus HU, Deml KF, Schmitz K, Meiboom M, Binot E, Hauke S, et al. Chromogenic in situ hybridization is a reliable assay for detection of ALK rearrangements in adenocarcinomas of the lung. Mod Pathol. 2013;26:1468–77.CrossRefPubMed
4.
Lewis JS Jr. Morphologic diversity in human papillomavirus-related oropharyngeal squamous cell carcinoma. Catch Me If You Can! Mod Pathol. 2017;30:44-s53.CrossRef
5.
Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261–9.CrossRefPubMed
6.
Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. AJCC cancer staging manual. 8th ed. Springer: Springer International Publishing; 2016.
7.
Satgunaseelan L, Chia N, Suh H, Virk S, Ashford B, Lum T, et al. p16 expression in cutaneous squamous cell carcinoma of the head and neck is not associated with integration of high risk HPV DNA or prognosis. Pathology. 2017;49:494–8.CrossRefPubMed
8.
Mirghani H, Casiraghi O, Amen F, He M, Ma XJ, Saulnier P, et al. Diagnosis of HPV-driven head and neck cancer with a single test in routine clinical practice. Mod Pathol. 2015;28:1518–27.CrossRefPubMed
9.
Rooper LM, Gandhi M, Bishop JA, Westra WH. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization. Oral Oncol. 2016;55:11–6.CrossRefPubMed
10.
Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, et al. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol. 2012;36:1874–82.CrossRefPubMedPubMedCentral
11.
Jalaly JB, Lewis JS Jr, Collins BT, Wu X, Ma XJ, Luo Y, et al. Correlation of p16 immunohistochemistry in FNA biopsies with corresponding tissue specimens in HPV-related squamous cell carcinomas of the oropharynx. Cancer Cytopathol. 2015;123:723–31.CrossRefPubMed
12.
Lewis JS Jr, Beadle B, Bishop JA, Chernock RD, Colasacco C, Lacchetti C, et al. Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline from the College of American Pathologists. Arch Pathol Lab Med. 2018;142:559–97.CrossRefPubMed
13.
Petersson B, Bell D, El-Mofty S, Gillison M, Lewis J, Nadal A, et al. Nasopharyngeal carcinoma. In: El-Naggar AK, Chan JK, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyons: IARC; 2017. p. 65–70.
14.
Weiss LM, Chen YY. EBER in situ hybridization for Epstein–Barr virus. Methods Mol Biol. 2013;999:223–30.CrossRefPubMed
15.
16.
Nakao K, Yuge T, Mochiki M, Nibu K, Sugasawa M. Detection of Epstein–Barr virus in metastatic lymph nodes of patients with nasopharyngeal carcinoma and a primary unknown carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129:338–40.CrossRefPubMed
17.
Pacchioni D, Negro F, Valente G, Bussolati G. Epstein–Barr virus detection by in situ hybridization in fine-needle aspiration biopsies. Diagn Mol Pathol. 1994;3:100–4.CrossRefPubMed
18.
Weiss LM, Movahed LA, Butler AE, Swanson SA, Frierson HF Jr, Cooper PH, et al. Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein–Barr viral genomes by in situ hybridization. Am J Surg Pathol. 1989;13:625–31.CrossRefPubMed
19.
Lin L, Lin T, Zeng B. Primary lymphoepithelioma-like carcinoma of the lung: an unusual cancer and clinical outcomes of 14 patients. Oncol Lett. 2017;14:3110–6.CrossRefPubMedPubMedCentral
20.
Gondim DD, Haynes W, Wang X, Chernock RD, El-Mofty SK, Lewis JS Jr. Histologic typing in oropharyngeal squamous cell carcinoma: a 4-year prospective practice study with p16 and high-risk HPV mRNA testing correlation. Am J Surg Pathol. 2016;40:1117–24.CrossRefPubMed
21.
Singhi AD, Stelow EB, Mills SE, Westra WH. Lymphoepithelial-like carcinoma of the oropharynx: a morphologic variant of HPV-related head and neck carcinoma. Am J Surg Pathol. 2010;34:800–5.CrossRefPubMed
22.
Dogan S, Hedberg ML, Ferris RL, Rath TJ, Assaad AM, Chiosea SI. Human papillomavirus and Epstein–Barr virus in nasopharyngeal carcinoma in a low-incidence population. Head Neck. 2014;36:511–6.CrossRefPubMed
23.
Galloway TJ, Ridge JA. Management of squamous cancer metastatic to cervical nodes with an unknown primary site. J Clin Oncol. 2015;33:3328–37.CrossRefPubMed
24.
Wang W, Feng M, Fan Z, Li J, Lang J. Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Biomed Res Int. 2014;2014:814948.PubMedPubMedCentral
25.
Badlani J, Gupta R, Balasubramanian D, Smith J, Luk P, Clark J. Primary salivary gland malignancies: a review of clinicopathological evolution, molecular mechanisms and management. ANZ J Surg. 2018;88:152–7.CrossRefPubMed
26.
Bell D, Bullerdiek J, Gnepp D, Schwartz M, Stenman G, Triantafyllou A. Pleomorphic adenoma. In: El-Naggar AK, Chan JK, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyons: IARC; 2017. p. 185–6.
27.
Ochal-Choinska AJ, Osuch-Wojcikiewicz E. Particular aspects in the cytogenetics and molecular biology of salivary gland tumours—current review of reports. Contemp Oncol. 2016;20:281–6.
28.
Astrom AK, Voz ML, Kas K, Roijer E, Wedell B, Mandahl N, et al. Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene. Cancer Res. 1999;59:918–23.PubMed
29.
Martins C, Fonseca I, Roque L, Pereira T, Ribeiro C, Bullerdiek J, et al. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry. Mod Pathol. 2005;18:1048–55.CrossRefPubMed
30.
Katabi N, Ghossein R, Ho A, Dogan S, Zhang L, Sung YS, et al. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts. Hum Pathol. 2015;46:26–33.CrossRefPubMed
31.
32.
Bahrami A, Dalton JD, Shivakumar B, Krane JF. PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases. Head Neck Pathol. 2012;6:328–35.CrossRefPubMedPubMedCentral
33.
Coca-Pelaz A, Rodrigo JP, Bradley PJ, Vander Poorten V, Triantafyllou A, Hunt JL, et al. Adenoid cystic carcinoma of the head and neck—an update. Oral Oncol. 2015;51:652–61.CrossRefPubMed
34.
35.
Persson M, Andren Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA. 2009;106:18740–4.CrossRefPubMedPubMedCentral
36.
Brill LB II, Kanner WA, Fehr A, Andren Y, Moskaluk CA, Loning T, et al. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod Pathol. 2011;24:1169–76.CrossRefPubMed
37.
Mitani Y, Li J, Rao PH, Zhao YJ, Bell D, Lippman SM, et al. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010;16:4722–31.CrossRefPubMedPubMedCentral
38.
West RB, Kong C, Clarke N, Gilks T, Lipsick JS, Cao H, et al. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. Am J Surg Pathol. 2011;35:92–9.CrossRefPubMedPubMedCentral
39.
Stenman G, Andersson MK, Andren Y. New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer. Cell Cycle. 2010;9:2986–95.CrossRefPubMedPubMedCentral
40.
Luk PP, Wykes J, Selinger CI, Ekmejian R, Tay J, Gao K, et al. Diagnostic and prognostic utility of mastermind-like 2 (MAML2) gene rearrangement detection by fluorescent in situ hybridization (FISH) in mucoepidermoid carcinoma of the salivary glands. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:530–41.CrossRefPubMed
41.
Noda H, Okumura Y, Nakayama T, Miyabe S, Fujiyoshi Y, Hattori H, et al. Clinicopathological significance of MAML2 gene split in mucoepidermoid carcinoma. Cancer Sci. 2013;104:85–92.CrossRefPubMed
42.
Chiosea SI, Dacic S, Nikiforova MN, Seethala RR. Prospective testing of mucoepidermoid carcinoma for the MAML2 translocation: clinical implications. Laryngoscope. 2012;122:1690–4.CrossRefPubMed
43.
Seethala RR, Dacic S, Cieply K, Kelly LM, Nikiforova MN. A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas. Am J Surg Pathol. 2010;34:1106–21.CrossRefPubMed
44.
Skalova A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34:599–608.PubMed
45.
Chiosea SI, Griffith C, Assaad A, Seethala RR. Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands. Histopathology. 2012;61:387–94.CrossRefPubMed
46.
Luk PP, Selinger CI, Eviston TJ, Lum T, Yu B, O’Toole SA, et al. Mammary analogue secretory carcinoma: an evaluation of its clinicopathological and genetic characteristics. Pathology. 2015;47:659–66.CrossRefPubMed
47.
Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2:367–76.CrossRefPubMed
48.
Lannon CL, Sorensen PH. ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. Semin Cancer Biol. 2005;15:215–23.CrossRefPubMed
49.
Ito Y, Ishibashi K, Masaki A, Fujii K, Fujiyoshi Y, Hattori H, et al. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion. Am J Surg Pathol. 2015;39:602–10.CrossRefPubMed
50.
Chi HT, Ly BT, Kano Y, Tojo A, Watanabe T, Sato Y. ETV6-NTRK3 as a therapeutic target of small molecule inhibitor PKC412. Biochem Biophys Res Commun. 2012;429:87–92.CrossRefPubMed
51.
Antonescu CR, Katabi N, Zhang L, Sung YS, Seethala RR, Jordan RC, et al. EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer. 2011;50:559–70.CrossRefPubMed
52.
Thway K, Fisher C. Tumors with EWSR1-CREB1 and EWSR1-ATF1 fusions: the current status. Am J Surg Pathol. 2012;36:e1–11.CrossRefPubMed
53.
Shah AA, LeGallo RD, van Zante A, Frierson HF Jr, Mills SE, Berean KW, et al. EWSR1 genetic rearrangements in salivary gland tumors: a specific and very common feature of hyalinizing clear cell carcinoma. Am J Surg Pathol. 2013;37:571–8.CrossRefPubMed
54.
Bilodeau EA, Weinreb I, Antonescu CR, Zhang L, Dacic S, Muller S, et al. Clear cell odontogenic carcinomas show EWSR1 rearrangements: a novel finding and a biological link to salivary clear cell carcinomas. Am J Surg Pathol. 2013;37:1001–5.CrossRefPubMed
55.
Luk PP, Weston JD, Yu B, Selinger CI, Ekmejian R, Eviston TJ, et al. Salivary duct carcinoma: clinicopathologic features, morphologic spectrum, and somatic mutations. Head Neck. 2016;38(Suppl 1):E1838–47.CrossRefPubMed
56.
Jayaprakash V, Merzianu M, Warren GW, Arshad H, Hicks WL Jr, Rigual NR, et al. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: analysis of 228 cases from the surveillance, epidemiology, and end results database. Head Neck. 2014;36:694–701.CrossRefPubMed
57.
Limaye SA, Posner MR, Krane JF, Fonfria M, Lorch JH, Dillon DA, et al. Trastuzumab for the treatment of salivary duct carcinoma. Oncologist. 2013;18:294–300.CrossRefPubMedPubMedCentral
58.
Thorpe LM, Schrock AB, Erlich RL, Miller VA, Knost J, Le-Lindqwister N, et al. Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature. Head Neck. 2017;39:E40-e4.CrossRef
59.
Galy-Bernadoy C, Garrel R. Head and neck soft-tissue sarcoma in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2016;133:37–42.CrossRefPubMed
60.
61.
Pasquali S, Hadjinicolaou AV, Chiarion Sileni V, Rossi CR, Mocellin S. Systemic treatments for metastatic cutaneous melanoma. Cochrane Database Syst Rev. 2018;2:Cd011123.PubMed
62.
Grevener K, Haveman LM, Ranft A, van den Berg H, Jung S, Ladenstein R, et al. Management and outcome of Ewing sarcoma of the head and neck. Pediatr Blood Cancer. 2016;63:604–10.CrossRefPubMed
63.
de Alava E. Ewing sarcoma, an update on molecular pathology with therapeutic implications. Surg Pathol Clin. 2017;10:575–85.CrossRefPubMed
64.
Fisher C. The diversity of soft tissue tumours with EWSR1 gene rearrangements: a review. Histopathology. 2014;64:134–50.CrossRefPubMed
65.
Owosho AA, Estilo CL, Huryn JM, Zhang L, Fletcher CDM, Antonescu CR. Head and neck round cell sarcomas: a comparative clinicopathologic analysis of 2 molecular subsets: Ewing and CIC-rearranged sarcomas. Head Neck Pathol. 2017;11:450–9.CrossRefPubMedPubMedCentral
66.
Smith SC, Buehler D, Choi EY, McHugh JB, Rubin BP, Billings SD, et al. CIC-DUX sarcomas demonstrate frequent MYC amplification and ETS-family transcription factor expression. Mod Pathol. 2015;28:57–68.CrossRefPubMed
67.
Radzikowska J, Kukwa W, Kukwa A, Czarnecka A, Krzeski A. Rhabdomyosarcoma of the head and neck in children. Contemp Oncol. 2015;19:98–107.
68.
Gallego Melcon S, Sanchez de Toledo Codina J. Molecular biology of rhabdomyosarcoma. Clin Transl Oncol. 2007;9:415–9.CrossRefPubMed
69.
Sumegi J, Streblow R, Frayer RW, Dal Cin P, Rosenberg A, Meloni-Ehrig A, et al. Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Genes Chromosomes Cancer. 2010;49:224–36.PubMedPubMedCentral
70.
Downs-Kelly E, Shehata BM, Lopez-Terrada D, Weaver J, Patel RM, Hartke M, et al. The utility of FOXO1 fluorescence in situ hybridization (FISH) in formalin-fixed paraffin-embedded specimens in the diagnosis of alveolar rhabdomyosarcoma. Diagn Mol Pathol. 2009;18:138–43.CrossRefPubMed
71.
Mehra S, de la Roza G, Tull J, Shrimpton A, Valente A, Zhang S. Detection of FOXO1 (FKHR) gene break-apart by fluorescence in situ hybridization in formalin-fixed, paraffin-embedded alveolar rhabdomyosarcomas and its clinicopathologic correlation. Diagn Mol Pathol. 2008;17:14–20.PubMed
72.
Carrillo R, Rodriguez-Peralto JL, Batsakis JG. Synovial sarcomas of the head and neck. Ann Otol Rhinol Laryngol. 1992;101:367–70.CrossRefPubMed
73.
Ren T, Lu Q, Guo W, Lou Z, Peng X, Jiao G, et al. The clinical implication of SS18-SSX fusion gene in synovial sarcoma. Br J Cancer. 2013;109:2279–85.CrossRefPubMedPubMedCentral
74.
Fritchie KJ, Jin L, Wang X, Graham RP, Torbenson MS, Lewis JE, et al. Fusion gene profile of biphenotypic sinonasal sarcoma: an analysis of 44 cases. Histopathology. 2016;69:930–6.CrossRefPubMed
75.
Bogucki B, Neuhaus I, Hurst EA. Dermatofibrosarcoma protuberans: a review of the literature. Dermatol Surg. 2012;38:537–51.CrossRefPubMed
76.
Noujaim J, Thway K, Fisher C, Jones RL. Dermatofibrosarcoma protuberans: from translocation to targeted therapy. Cancer Biol Med. 2015;12:375–84.PubMedPubMedCentral
77.
Karanian M, Perot G, Coindre JM, Chibon F, Pedeutour F, Neuville A. Fluorescence in situ hybridization analysis is a helpful test for the diagnosis of dermatofibrosarcoma protuberans. Mod Pathol. 2015;28:230–7.CrossRefPubMed
78.
Zhang Z, Chen H, Chen M, He X, Wang Y, Zhang H. Application of COL1A1-PDGFB fusion gene detection by fluorescence in situ hybridization in biopsy tissue of dermatofibrosarcoma protuberans. J Dermatol. 2017;44:798–802.CrossRefPubMed
79.
Segura S, Salgado R, Toll A, Martin-Ezquerra G, Yebenes M, Saez A, et al. Identification of t(17;22)(q22;q13) (COL1A1/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays. Hum Pathol. 2011;42:176–84.CrossRefPubMed
80.
81.
Tabatabaei SH, Jahanshahi G, Dehghan Marvasti F. Diagnostic challenges of low-grade central osteosarcoma of jaw: a literature review. J Dent. 2015;16:62–7.
82.
Dujardin F, Binh MB, Bouvier C, Gomez-Brouchet A, Larousserie F, Muret A, et al. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol. 2011;24:624–37.CrossRefPubMed
83.
84.
Dahlen A, Debiec-Rychter M, Pedeutour F, Domanski HA, Hoglund M, Bauer HC, et al. Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors. Int J Cancer. 2003;103:616–23.CrossRefPubMed
85.
Chen BJ, Marino-Enriquez A, Fletcher CD, Hornick JL. Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: an immunohistochemical study with diagnostic implications. Am J Surg Pathol. 2012;36:1119–28.CrossRefPubMed
86.
Italiano A, Bianchini L, Keslair F, Bonnafous S, Cardot-Leccia N, Coindre JM, et al. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer. 2008;122:2233–41.CrossRefPubMed
87.
Thway K, Wang J, Swansbury J, Min T, Fisher C. Fluorescence in situ hybridization for MDM2 amplification as a routine ancillary diagnostic tool for suspected well-differentiated and dedifferentiated liposarcomas: experience at a tertiary center. Sarcoma. 2015;2015:812089.CrossRefPubMedPubMedCentral
88.
Narendra S, Valente A, Tull J, Zhang S. DDIT3 gene break-apart as a molecular marker for diagnosis of myxoid liposarcoma—assay validation and clinical experience. Diagn Mol Pathol. 2011;20:218–24.CrossRefPubMed
89.
Shin C, Low I, Ng D, Oei P, Miles C, Symmans P. USP6 gene rearrangement in nodular fasciitis and histological mimics. Histopathology. 2016;69:784–91.CrossRefPubMed
90.
Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, et al. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Investig. 2011;91:1427–33.CrossRefPubMed
91.
Coffin CM, Fletcher J. Inflammatory myofibroblastic tumour. In: Fletcher C, Bridge J, Hogendoorn P, Mertens F, editors. WHO classification of tumours of soft tissue and bone. 4th ed. Lyons: IARC; 2013. p. 83–4.
92.
Huang YH, Tian YF, Li CF. Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement with bland cytological features mimicking desmoid-type fibromatosis: a case report and review of the literature. Oncol Lett. 2016;11:1429–34.CrossRefPubMedPubMedCentral
93.
Antonescu CR, Suurmeijer AJ, Zhang L, Sung YS, Jungbluth AA, Travis WD, et al. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement. Am J Surg Pathol. 2015;39:957–67.CrossRefPubMedPubMedCentral
94.
Zapater E, Bagan JV, Carbonell F, Basterra J. Malignant lymphoma of the head and neck. Oral Dis. 2010;16:119–28.CrossRefPubMed
95.
Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, et al. Burkitt’s lymphoma. Lancet. 2012;379:1234–44.CrossRefPubMed
96.
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.CrossRefPubMedPubMedCentral
97.
Tzankov A, Xu-Monette ZY, Gerhard M, Visco C, Dirnhofer S, Gisin N, et al. Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol. 2014;27:958–71.CrossRefPubMed
98.
Ventura RA, Martin-Subero JI, Jones M, McParland J, Gesk S, Mason DY, et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn. 2006;8:141–51.CrossRefPubMedPubMedCentral
99.
100.
Gupta R, Cooper WA, Selinger C, Mahar A, Anderson L, Buckland ME, et al. Fluorescent in situ hybridization in surgical pathology practice. Adv Anat Pathol. 2018;25:223–37.PubMed
101.
Bishop JA, Ogawa T, Stelow EB, Moskaluk CA, Koch WM, Pai SI, et al. Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract. Am J Surg Pathol. 2013;37:836–44.CrossRefPubMedPubMedCentral
102.
103.
Chau NG, Hurwitz S, Mitchell CM, Aserlind A, Grunfeld N, Kaplan L, et al. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck. Cancer. 2016;122:3632–40.CrossRefPubMed
104.
Bishop JA, Alaggio R, Zhang L, Seethala RR, Antonescu CR. Adamantinoma-like Ewing family tumors of the head and neck: a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas. Am J Surg Pathol. 2015;39:1267–74.CrossRefPubMedPubMedCentral
Metadata
Title
Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms
Authors
Peter P. Luk
Christina I. Selinger
Wendy A. Cooper
Annabelle Mahar
Carsten E. Palme
Sandra A. O’Toole
Jonathan R. Clark
Ruta Gupta
Publication date
01-09-2019
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 3/2019
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-018-0988-1

Other articles of this Issue 3/2019

Head and Neck Pathology 3/2019 Go to the issue

Original Paper

Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma

Proceeding of the North American Society of Head and Neck Pathology Companion Meeting, March 17, 2019, National Harbor, MD

Benign Fibro-Osseous Lesions of the Head and Neck

Original Paper

Acute Invasive Fungal Rhinosinusitis: Frozen Section Histomorphology and Diagnosis with PAS Stain

Original Paper

Sclerosing Odontogenic Carcinoma with Local Recurrence: Case Report and Review of Literature

Original Paper

Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases

Case Report

IgG4-Related Disease of the Thyroid Gland Requiring Emergent Total Thyroidectomy: A Case Report